Labomar Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Private

  • Employees
  • 365

Employees

  • Latest Deal Type
  • Debt - Acquisition

  • Financing Rounds
  • 9

  • Investments
  • 10

Labomar General Information

Description

Manufacturer of nutraceuticals, medical devices, cosmetics and foods for special medical purposes. The company provides bespoke product development and industrial-scale production through its in-house services, thereby ensuring high-quality and safe formulations for global healthcare

Contact Information

Website
www.labomar.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Via North Sauro, 35/l
  • 31036 Istrana(Treviso)
  • Italy
+39 0422
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Via North Sauro, 35/l
  • 31036 Istrana(Treviso)
  • Italy
+39 0422

Labomar Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Labomar Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Labomar‘s full profile, request access.

Request a free trial

Labomar Patents

Labomar Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026180963-A1 A composition comprising myrtus communis extract and olea europea extract for the maintenance and/or in the restoration of physiological blood lipid levels Pending 25-Feb-2025
WO-2026078513-A1 Formulation comprising a mucoadhesive, washout-resistant and film- forming association Pending 07-Oct-2024
WO-2026074521-A1 Emulsions for use in oral and cosmetic formulations Pending 04-Oct-2024
EP-4827409-A1 Compositions for improving the dispersion of probiotics in oily suspensions Pending 18-Dec-2023
WO-2025133941-A1 Compositions for improving the dispersion of probiotics in oily suspensions Inactive 18-Dec-2023 A23L33/135
To view Labomar’s complete patent history, request access »

Labomar Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Labomar Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Labomar‘s full profile, request access.

Request a free trial

Labomar Investments & Acquisitions (10)

Labomar’s most recent deal was a Buyout/LBO with Pharmia. The deal was made on 25-Sep-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Pharmia 25-Sep-2025 Buyout/LBO Medical Supplies
Laboratorios Entema 06-Aug-2024 Merger/Acquisition Personal Products
Sphera Encapsulation 01-Jul-2024 Merger/Acquisition Other Commercial Services
Sphera Encapsulation 01-Sep-2023 Corporate Other Commercial Services
Welcare Industries 27-Dec-2021 Secondary Transaction - Private Medical Supplies
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

Labomar Affiliates

Subsidiaries (7)

Name Industry Location Year Founded
Sphera Encapsulation Verona, Italy 2016
Welcare Research S.R.L. Societa Benefit Milan, Italy 2015
Labiotre Florence, Italy 2011
Welcare Industries Milan, Italy 2001
Laboratorios Entema Palau-solita i Plegamans, Spain 1995
You’re viewing 5 of 7 affiliates. Get the full list.  »

Labomar FAQs

  • When was Labomar founded?

    Labomar was founded in 1998.

  • Where is Labomar headquartered?

    Labomar is headquartered in Istrana, Italy.

  • What is the size of Labomar?

    Labomar has 365 total employees.

  • What industry is Labomar in?

    Labomar’s primary industry is Pharmaceuticals.

  • Is Labomar a private or public company?

    Labomar is a Private company.

  • What is Labomar’s current revenue?

    The current revenue for Labomar is .

  • How much funding has Labomar raised over time?

    Labomar has raised $186M.

  • Who are Labomar’s investors?

    CCP No. 7.2, Charterhouse Capital Partners, and LBM Holding have invested in Labomar.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process